These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 36147463)

  • 21. E3 ubiquitin ligase HECTD3 is a tumor suppressor and mediates the polyubiquitination of SLC7A11 to promote ferroptosis in colon cancer.
    Huang F; Huang Z; Wei Q; Liu G; Pu J
    Exp Cell Res; 2023 Sep; 430(1):113697. PubMed ID: 37422058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma with high expression of SLC7A11 is sensitive to erastin-induced ferroptosis.
    Zhang W; Li Q; Zhang Y; Wang Z; Yuan S; Zhang X; Zhao M; Zhuang W; Li B
    Apoptosis; 2024 Apr; 29(3-4):412-423. PubMed ID: 38001343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.
    Zhang X; Zheng X; Ying X; Xie W; Yin Y; Wang X
    J Transl Med; 2023 May; 21(1):334. PubMed ID: 37210575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11.
    Wang S; Yu H; Guo P; Feng L; Li Z
    Funct Integr Genomics; 2024 Sep; 24(5):163. PubMed ID: 39292359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma.
    Chen Q; Zheng W; Guan J; Liu H; Dan Y; Zhu L; Song Y; Zhou Y; Zhao X; Zhang Y; Bai Y; Pan Y; Zhang J; Shao C
    Cell Death Differ; 2023 Jan; 30(1):137-151. PubMed ID: 35995846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX7 inhibits the malignant progression of bladder cancer via the DNMT3B/CYGB axis.
    Zhang J; Zhang W; Liu J; Liu Y; Jiang Y; Ainiwaer A; Chen H; Gu Z; Chen H; Mao S; Guo Y; Xu T; Xu Y; Wu Y; Yao X; Yan Y
    Mol Biomed; 2024 Sep; 5(1):36. PubMed ID: 39227479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircRPPH1 promotes the stemness of gastric cancer cells by targeting miR-375/SLC7A11 axis.
    Liu J; Yang H; Deng J; Jiang R; Meng E; Wu H
    Environ Toxicol; 2023 Jan; 38(1):115-125. PubMed ID: 36190453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression.
    Liu J; Zhang C; Wu H; Sun XX; Li Y; Huang S; Yue X; Lu SE; Shen Z; Su X; White E; Haffty BG; Hu W; Feng Z
    J Clin Invest; 2020 Jun; 130(6):3253-3269. PubMed ID: 32478681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3/SLC7A11 axis.
    Wang Z; Shu W; Zhao R; Liu Y; Wang H
    Apoptosis; 2023 Aug; 28(7-8):1168-1183. PubMed ID: 37170022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SLC7A11 regulated by NRF2 modulates esophageal squamous cell carcinoma radiosensitivity by inhibiting ferroptosis.
    Feng L; Zhao K; Sun L; Yin X; Zhang J; Liu C; Li B
    J Transl Med; 2021 Aug; 19(1):367. PubMed ID: 34446045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pt3R5G inhibits colon cancer cell proliferation through inducing ferroptosis by down-regulating SLC7A11.
    Han L; Yan Y; Fan M; Gao S; Zhang L; Xiong X; Li R; Xiao X; Wang X; Ni L; Tong D; Huang C; Cao Y; Yang J
    Life Sci; 2022 Oct; 306():120859. PubMed ID: 35931199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GOLPH3 promotes tumor malignancy via inhibition of ferroptosis by upregulating SLC7A11 in cholangiocarcinoma.
    Yin Z; Liu Q; Gao Y; Wang R; Qi Y; Wang D; Chen L; Yin X; He M; Li W
    Mol Carcinog; 2024 May; 63(5):912-925. PubMed ID: 38390729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
    Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation.
    Yoshino H; Enokida H; Osako Y; Nohata N; Yonemori M; Sugita S; Kuroshima K; Tsuruda M; Tatarano S; Nakagawa M
    Mol Oncol; 2020 Sep; 14(9):2190-2202. PubMed ID: 32386122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11.
    Wang Y; Zhao Y; Wang H; Zhang C; Wang M; Yang Y; Xu X; Hu Z
    FEBS Open Bio; 2020 Apr; 10(4):637-643. PubMed ID: 32107878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma.
    Qian L; Wang F; Lu SM; Miao HJ; He X; Feng J; Huang H; Shi RF; Zhang JG
    J Immunol Res; 2022; 2022():1951620. PubMed ID: 35509981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
    Koppula P; Zhuang L; Gan B
    Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA HEPFAL accelerates ferroptosis in hepatocellular carcinoma by regulating SLC7A11 ubiquitination.
    Zhang B; Bao W; Zhang S; Chen B; Zhou X; Zhao J; Shi Z; Zhang T; Chen Z; Wang L; Zheng X; Chen G; Wang Y
    Cell Death Dis; 2022 Aug; 13(8):734. PubMed ID: 36008384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPCAT2 inhibits colorectal cancer progression via the PRMT1/SLC7A11 axis.
    Cao N; Zhang F; Yin J; Zhang J; Bian X; Zheng G; Li N; Lin Y; Luo L
    Oncogene; 2024 May; 43(22):1714-1725. PubMed ID: 38605214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.